Clinical Trial Update: Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty Sleeping [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating eszopiclone and lemborexant in adults with obstructive sleep apnea and low arousal threshold who have difficulty sleeping; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Dayvigo (lemborexant)
• Lunesta (eszopiclone)

Snippet

Sponsor: Flinders University | Conditions: OSA - Obstructive Sleep Apnea | Phase 2 | Status: NOT_YET_RECRUITING